Patents by Inventor Michele Bennet Kinrade

Michele Bennet Kinrade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7141391
    Abstract: Isolated polynucleotides encoding monkey and canine Melanin Concentrating Hormone (MCH) Type 2 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH receptor polypeptides, and isolated MCH receptor polypeptides are also provided. MCH receptor polynucleotides and polypeptides may be used, for example, to identify agents that specifically interact with MCH receptor. Such agents find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: November 28, 2006
    Assignee: Neurogen Corporation
    Inventors: Michele Bennet Kinrade, Robbin M. Brodbeck, Stephen M. Waters, James E. Krause
  • Patent number: 7078484
    Abstract: Isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH1R polypeptides, and isolated MCH1R polypeptides are also provided. MCH1R polynucleotides and polypeptides may be used, for example, to identify compounds that specifically interact with MCH receptor. Such compounds find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: July 18, 2006
    Assignee: Neurogen Corporation
    Inventors: Michele Bennet Kinrade, Robbin M. Brodbeck, Stephen M. Waters, James E. Krause
  • Publication number: 20030148457
    Abstract: Isolated polynucleotides encoding monkey and canine Melanin Concentrating Hormone (MCH) Type 2 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH receptor polypeptides, and isolated MCH receptor polypeptides are also provided. MCH receptor polynucleotides and polypeptides may be used, for example, to identify agents that specifically interact with MCH receptor. Such agents find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.
    Type: Application
    Filed: November 12, 2002
    Publication date: August 7, 2003
    Inventors: Michele Bennet Kinrade, Robbin M. Brodbeck, Stephen M. Waters, James E. Krause
  • Publication number: 20030114644
    Abstract: Isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH1R polypeptides, and isolated MCH1R polypeptides are also provided. MCH1R polynucleotides and polypeptides may be used, for example, to identify compounds that specifically interact with MCH receptor. Such compounds find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.
    Type: Application
    Filed: December 4, 2002
    Publication date: June 19, 2003
    Inventors: Michele Bennet Kinrade, Robbin M. Brodbeck, Stephen M. Waters, James E. Krause